Overview
Anton Razuvaev practices practicing medicine in Stockholm, Sweden.
Mr. Razuvaev is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Atherosclerosis, Carotid Artery Disease, and Stroke.
He is actively involved in clinical research, co-authoring 21 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Anton Razuvaev
Is Anton Razuvaev a top-rated expert for Atherosclerosis?
MediFind is an objective health platform that identifies experts based on real-world data. Anton Razuvaev is classified as an Advanced expert for Atherosclerosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Anton Razuvaev participate in research or clinical trials?
Yes. Anton Razuvaev has published 21 articles and abstracts on conditions like Atherosclerosis. You can view a list of Anton Razuvaev's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- AtherosclerosisMr. Razuvaev isAdvanced. Learn about Atherosclerosis.
- Carotid Artery DiseaseMr. Razuvaev isAdvanced. Learn about Carotid Artery Disease.
- Experienced
- StrokeMr. Razuvaev isExperienced. Learn about Stroke.